Phase 2 study for nonmetastatic extremity high‐grade osteosarcoma in pediatric and adolescent and young adult patients with a risk‐adapted strategy based on ABCB1/P‐glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS‐2)-Reference-Cited by-同舟云学术

Phase 2 study for nonmetastatic extremity high‐grade osteosarcoma in pediatric and adolescent and young adult patients with a risk‐adapted strategy based on ABCB1/P‐glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS‐2)

Published:2022-02-24 Issue:10 Volume:128 Page:1958-1966
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Palmerini Emanuela¹,Meazza Cristina²,Tamburini Angela³,Bisogno Gianni⁴,Ferraresi Virginia⁵,Asaftei Sebastian D.⁶,Milano Giuseppe M.⁷,Coccoli Luca⁸,Manzitti Carla⁹,Luksch Roberto²,Serra Massimo¹,Gambarotti Marco¹⁰,Donati Davide M.¹¹¹²,Scotlandi Katia¹³,Bertulli Rossella²,Favre Claudio³,Longhi Alessandra¹,Abate Massimo E.¹⁴,Perrotta Silverio¹⁵,Mascarin Maurizio¹⁶,D’Angelo Paolo¹⁷,Cesari Marilena¹,Staals Eric L.¹¹¹²,Marchesi Emanuela¹⁸,Carretta Elisa¹,Ibrahim Toni¹,Casali Paolo G.²,Picci Piero¹⁸,Fagioli Franca⁶¹⁹,Ferrari Stefano¹

Affiliation:

1. Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies IRCCS Istituto Ortopedico Rizzoli Bologna Italy

2. Pediatric Oncology Unit Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

3. Azienda Ospedaliera Universitaria A. Meyer Florence Italy

4. Hematology Oncology Division Department of Women's and Children's HealthUniversity of Padova Padua Italy

5. IRCCS Regina Elena National Cancer Institute Rome Italy

6. Azienda Ospedaliero Universitaria Pisana Pisa Italy

7. Pediatric Oncology Department Regina Margherita Children's HospitalAzienda Ospedaliera Universitaria, Città della Salute e della Scienza di Torino Turin Italy

8. IRCCS Bambino Gesù Children's Hospital Rome Italy

9. IRCCS Istituto G. Gaslini–Ospedale Pediatrico Genoa Italy

10. Department of Pathology IRCCS Istituto Ortopedico Rizzoli Bologna Italy

11. Third Orthopedic and Traumatologic Clinic Prevalently OncologicIRCCS Istituto Ortopedico Rizzoli Bologna Italy

12. Department of Biomedical and Neuromotor Sciences University of Bologna Bologna Italy

13. Laboratory of Experimental Oncology IRCCS Istituto Ortopedico Rizzoli Bologna Italy

14. Pediatric Oncology National Medical Specialization Center Santobono–Pausilipon Napoli Italy

15. Ematologia ed Oncologia Pediatrica Università degli Studi della Campania Luigi Vanvitelli Naples Italy

16. AYA Oncology and Pediatric Radiotherapy Unit IRCCS Centro di Riferimento Oncologico Aviano Italy

17. Oncoematologia Pediatrica Palermo Palermo Italy

18. Italian Sarcoma Group Bologna Italy

19. Department of Public Health and Pediatric Sciences University of Turin Turin Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34131

Reference28 articles.

1. Bone and Soft Tissue Tumors: Clinical Features, Imaging, Pathology and Treatment. 2nd ed.

2. Soft tissue and bone tumours in adults

3. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

4. Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and future directions of systemic therapy in high-grade bone sarcomas;N.N. Priorov Journal of Traumatology and Orthopedics;2024-07-04

2. Prolonged 14-day continuous infusion of high-dose ifosfamide for patients with relapsed and refractory high-grade osteosarcoma: a retrospective multicentre cohort study;BMC Cancer;2024-06-19

3. Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement;Clinical Cancer Research;2024-06-13

4. European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma;EJC Paediatric Oncology;2023-12

5. NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report;Frontiers in Oncology;2023-10-09